Monitoring prion protein stability by NMR

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 17-18, 2009, Pages 1069-1074

  Julien, Olivier ^a   Graether, Steffen P ^b   Sykes, Brian D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; PRION PROTEIN; UREA;

ARTICLE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; ANIMAL; CATTLE; CHEMICAL STRUCTURE; CHEMISTRY; PROTEIN CONFORMATION;

ANIMALIA; BOVINAE;

ANIMALS; CATTLE; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING; PRPC PROTEINS; UREA;

EID: 69849092356     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390903084504     Document Type: Article

References (34)

1. Apetri, A. C., and Surewicz, W. K. 2002. Kinetic intermediate in the folding of human prion protein. J. Biol. Chem. 277:44589-44592.
2. Apetri, A. C., Vanik, D. L., and Surewicz, W. K. 2005. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231. Biochemistry 44:15880-15888.
3. Baryshnikova, O. K., Williams, T. C., and Sykes, B. D. 2008. Internal pH indicators for biomolecular NMR. J. Biomol. NMR 41:5-7.
4. Cobb, N. J., Sonnichsen, F. D., McHaourab, H., and Surewicz, W. K. 2007. Molecular architecture of human prion protein amyloid: A parallel, in-register beta-structure. Proc. Natl. Acad. Sci. USA 104:18946-18951.
5. Collinge, J. 2001. Prion diseases of humans and animals: Their causes and molecular basis. Annu. Rev. Neurosci. 24:519-550.
6. Collinge, J., Sidle, K. C., Meads, J., Ironside, J., and Hill, A. F. 1996. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383:685-690.
7. Collinge, J., Whitfield, J., McKintosh, E., Beck, J., Mead, S., Thomas, D. J., and Alpers, M. P. 2006. Kuru in the 21st century-An acquired human prion disease with very long incubation periods. Lancet 367:2068-2074.
8. DeMarco, M. L., and Daggett, V. 2007. Molecular mechanism for low pH triggered misfolding of the human prion protein. Biochemistry 46:3045-3054.
9. Gerber, R., Tahiri-Alaoui, A., Hore, P. J., and James, W. 2008. Conformational pH dependence of intermediate states during oligomerization of the human prion protein. Protein Sci. 17:537-544.
10. Goldfarb, L. G., Haltia, M., Brown, P., Nieto, A., Kovanen, J, McCombie, W. R., Trapp, S., and Gajdusek, D. C. 1991. New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet 337:425.
11. Govaerts, C., Wille, H., Prusiner, S. B., and Cohen, F. E. 2004. Evidence for assembly of prions with left-handed beta-helices into 11trimers. Proc. Natl. Acad. Sci. USA 101:8342-8347.
12. Greene, R. F., and Pace, C. N. 1974. Urea and guanidine hydrochloride denaturation of ribonuclease, lysozyme, alpha-chymotrypsin, and betalactoglobulin. J. Biol. Chem. 249:5388-5393.
13. Griffith, J. S. 1967. Self-replication and scrapie. Nature 215:1043-1044.
14. Hsiao, K., Baker, H. F., Crow, T. J., Poulter, M., Owen, F., Terwilliger, J. D., Westaway, D., Ott, J., and Prusiner, S. B. 1989. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338: 342-345.
15. Legname, G., Baskakov, I. V., Nguyen, H. O., Riesner, D., Cohen, F. E., DeArmond, S. J., and Prusiner, S. B. 2004. Synthetic mammalian prions. Science 305:673-676.
16. Lopez Garcia, F., Zahn, R., Riek, R., and Wuthrich, K. 2000. NMR structure of the bovine prion protein. Proc. Natl. Acad. Sci. USA 97:8334-8339.
17. Martins, V. R., Linden, R., Prado, M. A., Walz, R., Sakamoto, A. C., Izquierdo, I., and Brentani, R. R. 2002. Cellular prion protein: on the road for functions. FEBS Lett. 512:25-28.
18. Medori, R., Tritschler, H. J., LeBlanc, A., Villare, F., Manetto, V., Chen, H. Y., Xue, R., Leal, S., Montagna, P., Cortelli, P., Tinuper, P., Avoni, P., Mochi, M., Baruzzi, A., Hauw, J., Lugaresi, E., Autilio-Gambetti, L., and Gambetti, P. 1992. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N. Engl. J. Med. 326:444-449.
19. Pan, K. M., Baldwin, M., Nguyen, J., Gasset, M., Serban, A., Groth, D., Mehlhorn, I., Huang, Z., Fletterick, R. J., Cohen, F. E., and Prusiner, S. B. 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-10966.
20. Paramithiotis, E., Pinard, M., Lawton, T., LaBoissiere, S., Leathers, V. L., Zou, W. Q., Estey, L. A., Lamontagne, J., Lehto, M. T., Kondejewski, L. H., Francoeur, G. P., Papadopoulos, M., Haghighat, A., Spatz, S. J., Head, M., Will, R., Ironside, J., O'Rourke, K., Tonelli, Q., Ledebur, H. C., Chakrabartty, A., and Cashman, N. R. 2003. A prion protein epitope selective for the pathologically misfolded conformation. Nat. Med. 9:893-899.
21. Prusiner, S. B. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136-144.
22. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383.
23. Riek, R., Hornemann, S., Wider, G., Billeter, M., Glockshuber, R., and Wuthrich, K. 1996. NMR structure of the mouse prion protein domain PrP(121-321). Nature 382:180-182.
24. Roucou, X., and LeBlanc, A. C. 2005. Cellular prion protein neuroprotective function: Implications in prion diseases. J. Mol. Med. 83:3-11.
25. Stahl, N., Borchelt, D. R., Hsiao, K., and Prusiner, S. B. 1987. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51: 229-240.
26. Swietnicki, W., Morillas, M., Chen, S. G., Gambetti, P., and Surewicz, W. K. 2000. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231. Biochemistry 39:424-431.
27. Swietnicki, W., Petersen, R. B., Gambetti, P., and Surewicz, W. K. 1998. Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem. 273:31048-31052.
28. Tateishi, J., Brown, P., Kitamoto, T., Hoque, Z. M., Roos, R., Wollman, R., Cervenakova, L., and Gajdusek, D. C. 1995. First experimental transmission of fatal familial insomnia. Nature 376:434-435.
29. Wasmer, C., Lange, A., Van Melckebeke, H., Siemer, A. B., Riek, R., and Meier, B. H. 2008. Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science 319:1523-1526.
30. Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A., and Smith, P. G. 1996. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
31. World Health Organization. 2002. World Health Organization. http://www.who.int/mediacentre/factsheets/fs113/en
32. Zahn, R., Liu, A., Luhrs, T., Riek, R., von Schroetter, C., Lopez Garcia, F., Billeter, M., Calzolai, L., Wider, G., and Wuthrich, K. 2000. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97:145-150.
33. Zahn, R., von Schroetter, C., and Wuthrich, K. 1997. Human prion proteins expressed in Escherichia coli and purified by high-affinity column refolding. FEBS Lett. 417:400-404.
34. Zuegg, J., and Gready, J. E. 1999. Molecular dynamics simulations of human prion protein: Importance of correct treatment of electrostatic interactions. Biochemistry 38:13862-13876.